These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21074290)

  • 1. Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis.
    Belzil VV; Daoud H; Desjarlais A; Bouchard JP; Dupré N; Camu W; Dion PA; Rouleau GA
    Neurobiol Aging; 2011 Mar; 32(3):555.e13-4. PubMed ID: 21074290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population.
    Sugihara K; Maruyama H; Kamada M; Morino H; Kawakami H
    Neurobiol Aging; 2011 Oct; 32(10):1923.e9-10. PubMed ID: 21550138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients.
    Johnson L; Miller JW; Gkazi AS; Vance C; Topp SD; Newhouse SJ; Al-Chalabi A; Smith BN; Shaw CE
    Neurobiol Aging; 2012 Dec; 33(12):2948.e15-7. PubMed ID: 22892313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of familial and sporadic amyotrophic lateral sclerosis with OPTN mutations in Japanese population.
    Naruse H; Takahashi Y; Kihira T; Yoshida S; Kokubo Y; Kuzuhara S; Ishiura H; Amagasa M; Murayama S; Tsuji S; Goto J
    Amyotroph Lateral Scler; 2012 Oct; 13(6):562-6. PubMed ID: 22708870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China.
    Yang L; Cheng Y; Jia X; Liu X; Li X; Zhang K; Shen D; Liu M; Guan Y; Liu Q; Cui L; Li X
    Neurobiol Aging; 2021 Jan; 97():149.e1-149.e8. PubMed ID: 32893042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of optineurin in amyotrophic lateral sclerosis.
    Maruyama H; Morino H; Ito H; Izumi Y; Kato H; Watanabe Y; Kinoshita Y; Kamada M; Nodera H; Suzuki H; Komure O; Matsuura S; Kobatake K; Morimoto N; Abe K; Suzuki N; Aoki M; Kawata A; Hirai T; Kato T; Ogasawara K; Hirano A; Takumi T; Kusaka H; Hagiwara K; Kaji R; Kawakami H
    Nature; 2010 May; 465(7295):223-6. PubMed ID: 20428114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients.
    van Blitterswijk M; van Vught PW; van Es MA; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 May; 33(5):1016.e1-7. PubMed ID: 21802176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS.
    Kwon MJ; Baek W; Ki CS; Kim HY; Koh SH; Kim JW; Kim SH
    Neurobiol Aging; 2012 May; 33(5):1017.e17-23. PubMed ID: 22244934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis.
    Del Bo R; Tiloca C; Pensato V; Corrado L; Ratti A; Ticozzi N; Corti S; Castellotti B; Mazzini L; Sorarù G; Cereda C; D'Alfonso S; Gellera C; Comi GP; Silani V;
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1239-43. PubMed ID: 21613650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of OPTN in French familial amyotrophic lateral sclerosis.
    Millecamps S; Boillée S; Chabrol E; Camu W; Cazeneuve C; Salachas F; Pradat PF; Danel-Brunaud V; Vandenberghe N; Corcia P; Le Forestier N; Lacomblez L; Bruneteau G; Seilhean D; Brice A; Feingold J; Meininger V; LeGuern E
    Neurobiol Aging; 2011 Mar; 32(3):557.e11-3. PubMed ID: 21220178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis.
    Teyssou E; Vandenberghe N; Moigneu C; Boillée S; Couratier P; Meininger V; Pradat PF; Salachas F; Leguern E; Millecamps S
    Neurobiol Aging; 2014 May; 35(5):1213.e9-1213.e12. PubMed ID: 24360741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS.
    Tümer Z; Bertelsen B; Gredal O; Magyari M; Nielsen KC; Lucamp ; Grønskov K; Brøndum-Nielsen K
    Neurobiol Aging; 2012 Jan; 33(1):208.e1-5. PubMed ID: 21852022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
    Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
    Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese.
    Iida A; Hosono N; Sano M; Kamei T; Oshima S; Tokuda T; Nakajima M; Kubo M; Nakamura Y; Ikegawa S
    Neurobiol Aging; 2012 Aug; 33(8):1843.e19-24. PubMed ID: 22402017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany.
    Weishaupt JH; Waibel S; Birve A; Volk AE; Mayer B; Meyer T; Ludolph AC; Andersen PM
    Neurobiol Aging; 2013 May; 34(5):1516.e9-15. PubMed ID: 23062601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis.
    Soong BW; Lin KP; Guo YC; Lin CC; Tsai PC; Liao YC; Lu YC; Wang SJ; Tsai CP; Lee YC
    Neurobiol Aging; 2014 Oct; 35(10):2423.e1-6. PubMed ID: 24908169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China.
    Li C; Ji Y; Tang L; Zhang N; He J; Ye S; Liu X; Fan D
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):485-9. PubMed ID: 26503823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis.
    Hewitt C; Kirby J; Highley JR; Hartley JA; Hibberd R; Hollinger HC; Williams TL; Ince PG; McDermott CJ; Shaw PJ
    Arch Neurol; 2010 Apr; 67(4):455-61. PubMed ID: 20385912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK.
    Kwok CT; Wang HY; Morris AG; Smith B; Shaw C; de Belleroche J
    J Neurol Sci; 2015 Feb; 349(1-2):209-13. PubMed ID: 25618255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.